{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:02:07Z","timestamp":1759341727824,"version":"3.38.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T00:00:00Z","timestamp":1298419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s11095-011-0389-6","type":"journal-article","created":{"date-parts":[[2011,2,22]],"date-time":"2011-02-22T20:37:34Z","timestamp":1298407054000},"page":"1561-1576","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacokinetic-Pharmacodynamic Modeling of the Inhibitory Effects of Naproxen on the Time-Courses of Inflammatory Pain, Fever, and the Ex Vivo Synthesis of TXB2 and PGE2 in Rats"],"prefix":"10.1007","volume":"28","author":[{"given":"Elke H. J.","family":"Krekels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Angesj\u00f6","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingemo","family":"Sj\u00f6gren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"\u00c4ngeby M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odd-Geir","family":"Berge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra A. G.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,23]]},"reference":[{"issue":"5","key":"389_CR1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.neuropharm.2008.01.001","volume":"54","author":"GT Whiteside","year":"2008","unstructured":"Whiteside GT, Adedoyin A, Leventhal L. Predictive validity of animal pain models? A comparison of the pharmacokinetic-pharmacodynamic relationship for pain drugs in rats and humans. Neuropharmacology. 2008;54(5):767\u201375.","journal-title":"Neuropharmacology"},{"issue":"2","key":"389_CR2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1124\/jpet.106.106377","volume":"319","author":"SS Negus","year":"2006","unstructured":"Negus SS, Vanderah TW, Brandt MR, Bilsky EJ, Becerra L, Borsook D. Preclinical assessment of candidate analgesic drugs: recent advances and future challenges. J Pharmacol Exp Ther. 2006;319(2):507\u201314.","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"389_CR3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/BF02342223","volume":"45","author":"A Mukherjee","year":"1996","unstructured":"Mukherjee A, Hale VG, Borga O, Stein R. Predictability of the clinical potency of NSAIDs from the preclinical pharmacodynamics in rats. Inflamm Res. 1996;45(11):531\u201340.","journal-title":"Inflamm Res"},{"issue":"5","key":"389_CR4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ejpain.2008.06.011","volume":"13","author":"DR Huntjens","year":"2009","unstructured":"Huntjens DR, Spalding DJ, Danhof M, Della Pasqua OE. Differences in the sensitivity of behavioural measures of pain to the selectivity of cyclo-oxygenase inhibitors. Eur J Pain. 2009;13(5):448\u201357.","journal-title":"Eur J Pain"},{"issue":"9\u201310","key":"389_CR5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.drudis.2007.03.009","volume":"12","author":"SR Sultana","year":"2007","unstructured":"Sultana SR, Roblin D, O\u2019Connell D. Translational research in the pharmaceutical industry: from theory to reality. Drug Discov Today. 2007;12(9\u201310):419\u201325.","journal-title":"Drug Discov Today"},{"issue":"12","key":"389_CR6","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2165\/00003088-200342120-00001","volume":"42","author":"WA Colburn","year":"2003","unstructured":"Colburn WA, Lee JW. Biomarkers, validation and pharmacokinetic-pharmacodynamic modelling. Clin Pharmacokinet. 2003;42(12):997\u20131022.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"389_CR7","first-page":"287","volume":"119","author":"D Vardeh","year":"2009","unstructured":"Vardeh D, Wang D, Costigan M, et al. COX2 in CNS neural cells mediates mechanical inflammatory pain hypersensitivity in mice. J Clin Invest. 2009;119(2):287\u201394.","journal-title":"J Clin Invest"},{"issue":"3","key":"389_CR8","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0022-3565(24)37166-6","volume":"283","author":"Y Zhang","year":"1997","unstructured":"Zhang Y, Shaffer A, Portanova J, Seibert K, Isakson PC. Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production. J Pharmacol Exp Ther. 1997;283(3):1069\u201375.","journal-title":"J Pharmacol Exp Ther"},{"issue":"25","key":"389_CR9","doi-asserted-by":"crossref","first-page":"12013","DOI":"10.1073\/pnas.91.25.12013","volume":"91","author":"K Seibert","year":"1994","unstructured":"Seibert K, Zhang Y, Leahy K, et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci U S A. 1994;91(25):12013\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"389_CR10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1096\/fj.05-4434fje","volume":"20","author":"TD Warner","year":"2006","unstructured":"Warner TD, Vojnovic I, Bishop-Bailey D, Mitchell JA. Influence of plasma protein on the potencies of inhibitors of cyclooxygenase-1 and -2. FASEB J. 2006;20(14):542\u20134.","journal-title":"FASEB J"},{"issue":"7","key":"389_CR11","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/rheumatology\/keh627","volume":"44","author":"DR Huntjens","year":"2005","unstructured":"Huntjens DR, Danhof M, Della Pasqua OE. Pharmacokinetic-pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors. Rheumatology (Oxford). 2005;44(7):846\u201359.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"389_CR12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/BF02265118","volume":"45","author":"C Brideau","year":"1996","unstructured":"Brideau C, Kargman S, Liu S, et al. A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors. Inflamm Res. 1996;45(2):68\u201374.","journal-title":"Inflamm Res"},{"issue":"1","key":"389_CR13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jneumeth.2005.03.002","volume":"147","author":"J Tomazetti","year":"2005","unstructured":"Tomazetti J, Avila DS, Ferreira AP, et al. Baker yeast-induced fever in young rats: characterization and validation of an animal model for antipyretics screening. J Neurosci Methods. 2005;147(1):29\u201335.","journal-title":"J Neurosci Methods"},{"issue":"3","key":"389_CR14","first-page":"157","volume":"1","author":"E Arrigoni-Martelli","year":"1979","unstructured":"Arrigoni-Martelli E. Screening and assessment of antiinflammatory drugs. Methods Find Exp Clin Pharmacol. 1979;1(3):157\u201377.","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"1\u20132","key":"389_CR15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/s0304-3959(02)00382-2","volume":"102","author":"DH Vrinten","year":"2003","unstructured":"Vrinten DH, Hamers FF. \u2018CatWalk\u2019 automated quantitative gait analysis as a novel method to assess mechanical allodynia in the rat; a comparison with von Frey testing. Pain. 2003;102(1\u20132):203\u20139.","journal-title":"Pain"},{"issue":"1","key":"389_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneumeth.2008.06.017","volume":"174","author":"K Angeby-Moller","year":"2008","unstructured":"Angeby-Moller K, Berge OG, Hamers FP. Using the CatWalk method to assess weight-bearing and pain behaviour in walking rats with ankle joint monoarthritis induced by carrageenan: effects of morphine and rofecoxib. J Neurosci Methods. 2008;174(1):1\u20139.","journal-title":"J Neurosci Methods"},{"issue":"2","key":"389_CR17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF02353538","volume":"22","author":"ER Garrett","year":"1994","unstructured":"Garrett ER. The Bateman function revisited: a critical reevaluation of the quantitative expressions to characterize concentrations in the one compartment body model as a function of time with first-order invasion and first-order elimination. J Pharmacokinet Biopharm. 1994;22(2):103\u201328.","journal-title":"J Pharmacokinet Biopharm"},{"issue":"1","key":"389_CR18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1124\/jpet.105.095224","volume":"317","author":"SA Visser","year":"2006","unstructured":"Visser SA, Sallstrom B, Forsberg T, Peletier LA, Gabrielsson J. Modeling drug- and system-related changes in body temperature: application to clomethiazole-induced hypothermia, long-lasting tolerance development, and circadian rhythm in rats. J Pharmacol Exp Ther. 2006;317(1):209\u201319.","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"389_CR19","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1021\/js980171q","volume":"87","author":"A Sharma","year":"1998","unstructured":"Sharma A, Ebling WF, Jusko WJ. Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena. J Pharm Sci. 1998;87(12):1577\u201384.","journal-title":"J Pharm Sci"},{"issue":"4","key":"389_CR20","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/sj.bjp.0706737","volume":"148","author":"DR Huntjens","year":"2006","unstructured":"Huntjens DR, Spalding DJ, Danhof M, Della Pasqua OE. Correlation between in vitro and in vivo concentration-effect relationships of naproxen in rats and healthy volunteers. Br J Pharmacol. 2006;148(4):396\u2013404.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"389_CR21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0022-3565(24)29528-8","volume":"297","author":"M Josa","year":"2001","unstructured":"Josa M, Urizar JP, Rapado J, et al. Pharmacokinetic\/pharmacodynamic modeling of antipyretic and anti-inflammatory effects of naproxen in the rat. J Pharmacol Exp Ther. 2001;297(1):198\u2013205.","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"389_CR22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/jps.2600610507","volume":"61","author":"R Runkel","year":"1972","unstructured":"Runkel R, Chaplin M, Boost G, Segre E, Forchielli E. Absorption, distribution, metabolism, and excretion of naproxen in various laboratory animals and human subjects. J Pharm Sci. 1972;61(5):703\u20138.","journal-title":"J Pharm Sci"},{"issue":"4","key":"389_CR23","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2165\/00003088-199732040-00002","volume":"32","author":"NM Davies","year":"1997","unstructured":"Davies NM, Anderson KE. Clinical pharmacokinetics of naproxen. Clin Pharmacokinet. 1997;32(4):268\u201393.","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl 4","key":"389_CR24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/03331024860060S409","volume":"6","author":"S Moyer","year":"1986","unstructured":"Moyer S. Pharmacokinetics of naproxen sodium. Cephalalgia. 1986;6 Suppl 4:77\u201380.","journal-title":"Cephalalgia"},{"issue":"9","key":"389_CR25","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/0006-2952(92)90084-V","volume":"44","author":"S Ismail","year":"1992","unstructured":"Ismail S, Back DJ, Edwards G. The effect of malaria infection on 3\u2032-azido-3\u2032-deoxythymidine and paracetamol glucuronidation in rat liver microsomes. Biochem Pharmacol. 1992;44(9):1879\u201382.","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"389_CR26","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1172\/JCI107120","volume":"51","author":"CS Song","year":"1972","unstructured":"Song CS, Gelb NA, Wolff SM. The influence of pyrogen-induced fever on salicylamide metabolism in man. J Clin Invest. 1972;51(11):2959\u201366.","journal-title":"J Clin Invest"},{"issue":"2","key":"389_CR27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.2042-7158.1998.tb06180.x","volume":"50","author":"FA Santos","year":"1998","unstructured":"Santos FA, Rao VS. A study of the anti-pyretic effect of quinine, an alkaloid effective against cerebral malaria, on fever induced by bacterial endotoxin and yeast in rats. J Pharm Pharmacol. 1998;50(2):225\u20139.","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"389_CR28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3109\/07420529409057238","volume":"11","author":"B Bruguerolle","year":"1994","unstructured":"Bruguerolle B, Roucoules X. Time-dependent changes in body temperature rhythm induced in rats by brewer\u2019s yeast injection. Chronobiol Int. 1994;11(3):180\u20136.","journal-title":"Chronobiol Int"},{"issue":"6","key":"389_CR29","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0531-5565(90)90019-X","volume":"25","author":"R Refinetti","year":"1990","unstructured":"Refinetti R, Ma H, Satinoff E. Body temperature rhythms, cold tolerance, and fever in young and old rats of both genders. Exp Gerontol. 1990;25(6):533\u201343.","journal-title":"Exp Gerontol"},{"issue":"1\u20132","key":"389_CR30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0091-3057(01)00736-5","volume":"72","author":"MD Dogan","year":"2002","unstructured":"Dogan MD, Ataoglu H, Akarsu ES. Characterization of the hypothermic component of LPS-induced dual thermoregulatory response in rats. Pharmacol Biochem Behav. 2002;72(1\u20132):143\u201350.","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"389_CR31","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/BF01983660","volume":"16","author":"H Nakamura","year":"1985","unstructured":"Nakamura H, Mizushima Y, Seto Y, Motoyoshi S, Kadokawa T. Dexamethasone fails to produce antipyretic and analgesic actions in experimental animals. Agents Actions. 1985;16(6):542\u20137.","journal-title":"Agents Actions"},{"issue":"1","key":"389_CR32","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pharmthera.2005.10.013","volume":"111","author":"CM Blatteis","year":"2006","unstructured":"Blatteis CM. Endotoxic fever: new concepts of its regulation suggest new approaches to its management. Pharmacol Ther. 2006;111(1):194\u2013223.","journal-title":"Pharmacol Ther"},{"issue":"9","key":"389_CR33","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1371\/journal.pbio.0040284","volume":"4","author":"AA Steiner","year":"2006","unstructured":"Steiner AA, Ivanov AI, Serrats J, et al. Cellular and molecular bases of the initiation of fever. PLoS Biol. 2006;4(9):e284.","journal-title":"PLoS Biol"},{"key":"389_CR34","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.2741\/1690","volume":"10","author":"AA Romanovsky","year":"2005","unstructured":"Romanovsky AA, Almeida MC, Aronoff DM, et al. Fever and hypothermia in systemic inflammation: recent discoveries and revisions. Front Biosci. 2005;10:2193\u2013216.","journal-title":"Front Biosci"},{"issue":"4","key":"389_CR35","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1152\/japplphysiol.00485.2002","volume":"94","author":"G Ross","year":"2003","unstructured":"Ross G, Hubschle T, Pehl U, et al. Fever induction by localized subcutaneous inflammation in guinea pigs: the role of cytokines and prostaglandins. J Appl Physiol. 2003;94(4):1395\u2013402.","journal-title":"J Appl Physiol"},{"issue":"1\u20132","key":"389_CR36","first-page":"89","volume":"14","author":"TJ Bueters","year":"2008","unstructured":"Bueters TJ, Hoogstraate J, Visser SA. Correct assessment of new compounds using in vivo screening models can reduce false positives. Drug Discov Today. 2008;14(1\u20132):89\u201394.","journal-title":"Drug Discov Today"},{"issue":"1 Pt 2","key":"389_CR37","first-page":"R332","volume":"275","author":"AA Romanovsky","year":"1998","unstructured":"Romanovsky AA, Kulchitsky VA, Simons CT, Sugimoto N. Methodology of fever research: why are polyphasic fevers often thought to be biphasic? Am J Physiol. 1998;275(1 Pt 2):R332\u20138.","journal-title":"Am J Physiol"},{"issue":"2 Pt 2","key":"389_CR38","first-page":"R280","volume":"269","author":"AA Romanovsky","year":"1995","unstructured":"Romanovsky AA, Blatteis CM. Biphasic fever: what triggers the second temperature rise? Am J Physiol. 1995;269(2 Pt 2):R280\u20136.","journal-title":"Am J Physiol"},{"issue":"2","key":"389_CR39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/jpet.107.122283","volume":"322","author":"ML Capone","year":"2007","unstructured":"Capone ML, Tacconelli S, Sciulli MG, et al. Human pharmacology of naproxen sodium. J Pharmacol Exp Ther. 2007;322(2):453\u201360.","journal-title":"J Pharmacol Exp Ther"},{"issue":"13","key":"389_CR40","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","volume":"96","author":"TD Warner","year":"1999","unstructured":"Warner TD, Guiliano F, Vojnovic I, Bukasa A, Mitchell JA. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA. 1999;96(13):7563\u20138.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-011-0389-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-011-0389-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-011-0389-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T22:32:52Z","timestamp":1740954772000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-011-0389-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,23]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["389"],"URL":"https:\/\/doi.org\/10.1007\/s11095-011-0389-6","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"type":"print","value":"0724-8741"},{"type":"electronic","value":"1573-904X"}],"subject":[],"published":{"date-parts":[[2011,2,23]]}}}